Kazia Therapeutics (KZIA) Receivables (2009 - 2025)
Kazia Therapeutics (KZIA) posted Receivables of $207175.2 for Q4 2025, up 205.44% on a QoQ basis from $67828.9 in Q2 2025, and up 229.55% year-over-year from $62866.2 in Q4 2024.
Kazia Therapeutics (KZIA) Receivables (2009 - 2025) Analysis & Trends
Kazia Therapeutics' Receivables history runs 17 years deep, the most recent figure standing at $207175.2 for Q4 2025.
- Quarterly Receivables rose 229.55% year-over-year to $207175.2 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $207175.2 (up 229.55% YoY) and the FY2025 annual result came in at $67828.9, down 97.36% from the prior year.
- Receivables was $207175.2 for Q4 2025 at Kazia Therapeutics, up from $67828.9 in the prior quarter.
- Across five years, Receivables topped out at $58.5 million in Q4 2021 and bottomed at $62866.2 in Q4 2024.
- A 5-year average of $6.9 million and a median of $1.3 million in 2022 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables soared 2751.34% — and 2024, when it slumped 97.45%.
- Kazia Therapeutics' Receivables stood at $58.5 million in 2021, then sank by 95.83% to $2.4 million in 2022, then climbed by 0.88% to $2.5 million in 2023, then slumped by 97.45% to $62866.2 in 2024, then soared by 229.55% to $207175.2 in 2025.
- Business Quant data shows KZIA's Receivables at $207175.2 in Q4 2025, $67828.9 in Q2 2025, and $62866.2 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | 207,175.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 207,175.19 |
| Jun 30, 2025 | 67,828.92 |
| Dec 31, 2024 | 62,866.16 |
| Jun 30, 2024 | 2.57 Mn |
| Dec 31, 2023 | 2.46 Mn |
| Jun 30, 2023 | 2.68 Mn |
| Dec 31, 2022 | 2.44 Mn |
| Jun 30, 2022 | 93,831.15 |
| Dec 31, 2021 | 58.50 Mn |
| Jun 30, 2021 | 123,208.82 |
| Dec 31, 2020 | 52.91 Mn |
| Jun 30, 2020 | 618,061.65 |
| Dec 31, 2019 | 635,370.46 |
| Jun 30, 2019 | 1.59 Mn |
| Dec 31, 2018 | 2.33 Mn |
| Jun 30, 2018 | 1.92 Mn |
| Jun 30, 2017 | 3.42 Mn |
| Dec 31, 2016 | 4.16 Mn |
| Jun 30, 2016 | 3.18 Mn |
| Dec 31, 2015 | 108,673.21 |